Search Results 1721-1730 of 21461 for anti-TNF drugs

1. Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Bevacizumab or Ipilimumab as First-Line Therapy in Treating Patients with Stage IV Melanoma that Cannot be Removed by Surgery - Mayo Clinic

   By condition, treatment or drug name. Search ... Drugs used in chemotherapy, such as paclitaxel ... Any anti-cancer therapy (including immunotherapy) ...

2. Inotuzumab Ozogamicin in Treating Younger Patients With Relapsed or Refractory CD22 Positive B Acute Lymphoblastic Leukemia - Mayo Clinic

   Drugs & Supplements A-Z · Health Books · Healthy Living Program · Mayo ... Patients who are currently receiving or plan to receive other anti-cancer agents ...

3. Acyclovir (Oral Route, Intravenous Route) Proper Use - Mayo Clinic

   To help clear up your herpes infection, chickenpox, or shingles, keep taking acyclovir for the full time of treatment, even if your symptoms begin to clear up ...

4. Publications - Pierre Noel, M.D. - Mayo Clinic

   Safety and efficacy of the monoclonal anti-interleukin-5 antibody SCH55700 in the treatment of patients with hypereosinophilic syndrome. Blood. 2004 Apr 15 ...

5. Nirmatrelvir And Ritonavir (Oral Route) Description and Brand Names - Mayo Clinic

   Description and Brand Names. Drug information provided by: Merative, Micromedex®. US Brand Name. Paxlovid. Descriptions. Nirmatrelvir and ritonavir ...

6. Testosterone (Oral Route) Description and Brand Names - Mayo Clinic

   Testosterone is used for the treatment of men whose bodies do not make enough natural testosterone, a condition called hypogonadism. Testosterone is a male ...

7. Study to Determine the Safety and Effectiveness of CLS-TA in Combination with an Intravitreal Anti-VEGF Agent in Subjects with Retinal Vein Occlusion - Mayo Clinic

   Drugs & Supplements A-Z · Health Books · Healthy ... By condition, treatment or drug name. Search tips ... anti-VEGF agent ("intravitreal anti-VEGF agent ...

8. A Study to Evaluate the Optune® (Tumor Treating Fields) Concomitant with RT & TMZ to Treat Newly-diagnosed Glioblastoma - Mayo Clinic

   Any other cytotoxic or biologic anti-tumor therapy received prior to enrollment will be considered exclusion. Admitted to an institution by administrative ...

9. Doxorubicin Hydrochloride, Vinblastine, Dacarbazine, Brentuximab Vedotin, and Nivolumab in Treating Patients With Stage I-II Hodgkin Lymphoma - Mayo Clinic

   Requires therapy with agents ... agents, corticosteroids or immunosuppressive drugs). ... Received prior therapy with an anti-PD-1, anti-PD-L1, or anti-PD-L2 agent.

10. About the Cancer Center - Mayo Clinic Comprehensive Cancer Center Research

    Mayo Clinic Comprehensive Cancer Center sets the bar for excellence in research, clinical trials and cancer patient care and treatment.